Related Experiment Video

Updated: Aug 18, 2026

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
13:18

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression

Published on: April 10, 2026

Successful treatment of status migrainosus after electroconvulsive therapy with dihydroergotamine

Matt Stead1, Keith A Josephs

  • 1Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.

Headache
|April 20, 2005
PubMed

Abstract:

We describe a case of status migrainosus precipitated by electroconvulsive therapy (ECT) that was refractory to treatment with triptan medications but which resolved with dihydroergotamine (DHE). We briefly review some of the receptor pharmacology possibly related to this observation.

More Related Videos

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

Related Experiment Videos

Last Updated: Aug 18, 2026

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
13:18

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression

Published on: April 10, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...

Articles linked to this work by shared authors, journal, and citation graph.

Investigating the feasibility of 18F-flortaucipir PET imaging in the antemortem diagnosis of primary age-related tauopathy (PART): An observational imaging-pathological study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2024

Baseline multimodal imaging to predict longitudinal clinical decline in atypical Alzheimer's disease.

Cortex; a journal devoted to the study of the nervous system and behavior·2024

Automatic Speech Recognition in Primary Progressive Apraxia of Speech.

Journal of speech, language, and hearing research : JSLHR·2024

Relationships between regional burden of tau pathology and age at death and disease duration in PSP.

Parkinsonism & related disorders·2024

Patterns of glucose hypometabolism can help differentiate FTLD-FET from other types of FTLD.

Journal of neurology·2024

Incidence of Primary Progressive Apraxia of Speech and Primary Progressive Aphasia in Olmsted County, MN, 2011-2022.

Neurology·2024

Mitochondrial migraine: A multicenter study based on mitochondrial diseases presenting as encephalopathy and/or myopathy.

Headache·2026

Anti-calcitonin gene-related peptide treatments in women's health: Gaps and clinical evidence in menstrual-related migraine, pregnancy, lactation, and hormonal contraception: A narrative review.

Headache·2026

Orofacial pain disorder or trigeminal autonomic cephalalgia? Insights into pathophysiology and implications in medicine and dentistry.

Headache·2026

Re-evaluation of the dinosaur tail sign: Analysis of spinal magnetic resonance imaging signs in patients with chronic post-dural-puncture headache.

Headache·2026

Novel targets in headache: A narrative review.

Headache·2026

The association between sleep duration and migraine frequency, disability, and perceived stress in the Headache Assessment via a Digital Platform in United States (HeAD-US) study.

Headache·2026

Elevated asymmetric dimethylarginine drives hematopoietic stem cell metabolic reprogramming and dysfunction in chronic kidney disease.

Experimental cell research·2026

The hidden burden of topical corticosteroid misuse: a systematic review of dermatologic complications.

Current medical research and opinion·2026

Curcumin Delivery Systems for Inflammatory Skin Application: A Review.

Phytotherapy research : PTR·2026

Engineered naringenin-loaded nanoscale coordination polymers for targeted treatment of acute kidney injury.

Materials today. Bio·2026

Modification of the existing maximum residue levels for propyzamide in oilseeds and honey.

EFSA journal. European Food Safety Authority·2026

Pulmonary Arterial Hypertension Associated With Chronic Mephedrone Use: A Case Report.

Pulmonary circulation·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us